Vimarsana
Biggest News Aggregation in the World

Page 30 - Additional Professor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Additional Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Additional Professor Today - Breaking & Trending Today

COVID-19: Covaxin shows 50% effectiveness, says Lancet - Vimarsana News

COVID-19: Covaxin shows 50% effectiveness, says Lancet

The odds of vaccination with Covaxin were compared between cases and controls and adjusted for occupational exposure to COVID-19, previous SARS-CoV-2 infection, and infection dates.

Covaxin shows 50% effectiveness against Covid Delta variant, says study published in Lancet - Vimarsana News

Covaxin shows 50% effectiveness against Covid Delta variant, says study published in Lancet

Two doses of Covaxin are 50 per cent effective against the Delta variant of coronavirus disease, according to the first real-world assessment of India's indigenous Covid-19 vaccine published in The Lancet Infectious Diseases journal.

Covaxin 50% effective against delta variant, shows study - Here's all you need to know - Vimarsana News

Covaxin 50% effective against delta variant, shows study - Here's all you need to know

Two doses of Covaxin have shown 50 per cent effectiveness against symptomatic disease, according to the first real-world assessment of India's indigenous COVID-19 vaccine.

Coronavirus: Covaxin 50% Effective When Delta Was Dominant, Shows Lancet Study - Vimarsana News

Coronavirus: Covaxin 50% Effective When Delta Was Dominant, Shows Lancet Study

Two doses of Covaxin are 50 per cent effective against symptomatic disease, according to the first real-world assessment of India's indigenous COVID-19 vaccine published in The Lancet Infectious Diseases journal.

Source: ndtv.com
Covaxin shows 50 per cent effectiveness against symptomatic Covid in real-world assessment: Lancet study - Vimarsana News

Covaxin shows 50 per cent effectiveness against symptomatic Covid in real-world assessment: Lancet study

New Delhi, November 24 Two doses of Covaxin are 50 per cent effective against symptomatic Covid, according to the first real-world assessment of India's indigenous coronavirus vaccine published in Th